Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis

References

• World Health Organization (WHO). Global tuberculosis report 2015. Available at: http://www.who.int/tb/publications/global_report/en/. Accessed: January 20, 2016
   Google Scholar
• Montagnani C, Chiappini E, Galli L, de Martino M. Vaccine against tuberculosis: what's new? BMC Infect Dis 2014; 14 Suppl 1:S2; PMID:24564340; https://doi.org/10.1186/1471-2334-14-S1-S2
   PubMed Web of Science ®Google Scholar
• Ahsan MJ. Recent advances in the development of vaccines for tuberculosis. Ther Adv Vaccines 2015; 3:66-75; PMID:26288734; https://doi.org/10.1177/2051013615593891
   PubMedGoogle Scholar
• Gröschel MI, Prabowo SA, Cardona PJ, Stanford JL, van der Werf TS. Therapeutic vaccines for tuberculosis–a systematic review. Vaccine 2014; 32:3162-8; PMID:24726245; https://doi.org/10.1016/j.vaccine.2014.03.047
   PubMed Web of Science ®Google Scholar
• Bonickse R, Juhasz E. [Description of the new species Mycobacterium vaccae n. sp]. Zentralbl Bakteriol Orig 1964; 192:133-5. [ Article in German]
   PubMedGoogle Scholar
• Stanford J, Stanford C, Grange J. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front Biosci 2004; 9:1701-19; PMID:14977580; https://doi.org/10.2741/1292
   PubMed Web of Science ®Google Scholar
• Efremenko YV, Butov DA, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, et al. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7). Hum Vaccin Immunother 2013; 9:1852-6; PMID:23782489; https://doi.org/10.4161/hv.25280
   PubMed Web of Science ®Google Scholar
• Grange JM, Bottasso O, Stanford CA, Stanford JL. The use of mycobacterial adjuvant-based agents for immunotherapy of cancer. Vaccine 2008; 26(39):4984-90; PMID:18625281; https://doi.org/10.1016/j.vaccine.2008.06.092
   PubMed Web of Science ®Google Scholar
• Walker C, Sawicka E, Rook GA. Immunotherapy with mycobacteria. Curr Opin Allergy Clin Immunol 2003; 3:481-6; PMID:14612673; https://doi.org/10.1097/00130832-200312000-00010
   PubMed Web of Science ®Google Scholar
• Yang XY, Chen QF, Li YP, Wu SM. Mycobacterium vaccae as adjuvant therapy to anti-tuberculosis chemotherapy in never-treated tuberculosis patients: a meta-analysis. PloS One 2011; 6:e23826; PMID:21909406; https://doi.org/10.1371/journal.pone.0023826
   PubMed Web of Science ®Google Scholar
• Luo Y, Lu S, Guo S. [Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2000; 23:85-8. [ Article in Chinese]; PMID:11778496
   PubMedGoogle Scholar
• Dlugovitzky D, Fiorenza G, Farroni M, Bogue C, Stanford C, Stanford J. Immunological consequences of three doses of heat-killed Mycobacterium vaccae in the immunotherapy of tuberculosis. Respir Med 2006; 100:1079-87; PMID:16278080; https://doi.org/10.1016/j.rmed.2005.09.026
   PubMed Web of Science ®Google Scholar
• de Bruyn G, Garner P. Mycobacterium vaccae immunotherapy for treating tuberculosis. Cochrane Database Syst Rev 2003; (1):CD001166; PMID:12535403
   PubMedGoogle Scholar
• Yang XY, Chen QF, Cui XH, Yu Y, Li YP. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis. J Infect 2010; 60:320-30; PMID:20156481; https://doi.org/10.1016/j.jinf.2010.02.005
   PubMed Web of Science ®Google Scholar
• Butov DA, Efremenko YV, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, et al. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7). Immunotherapy 2013; 5:1047-54; PMID:24088075; https://doi.org/10.2217/imt.13.110
   PubMed Web of Science ®Google Scholar
• Johnson JL, Nunn AJ, Fourie PB, Ormerod LP, Mugerwa RD, Mwinga A, Chintu C, Ngwira B, Onyebujoh P, Zumla A. Effect of Mycobacterium vaccae (SRL172) immunotherapy on radiographic healing in tuberculosis. Int J Tuberc Lung Dis 2004; 8:1348-54; PMID:15581204
   PubMed Web of Science ®Google Scholar
• Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A; LUSKAR collaboration. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Lancet 2002; 360:1050-5; PMID:12383985; https://doi.org/10.1016/S0140-6736(02)11141-X
   PubMed Web of Science ®Google Scholar
• Luo Y; National Cooperation Group On Clinical Study Of Mycobacterium Vaccae V. [The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2001; 24:43-7. [ Article in Chinese]; PMID:11802939
   PubMedGoogle Scholar
• Mayo RE, Stanford JL. Double-blind placebo-controlled trial of Mycobacterium vaccae immunotherapy for tuberculosis in KwaZulu, South Africa, 1991-97. Trans R Soc Trop Med Hyg 2000; 94:563-8; PMID:11132390; https://doi.org/10.1016/S0035-9203(00)90088-9
   PubMed Web of Science ®Google Scholar
• Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, et al. Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration. J Infect Dis 2000; 181:1304-12; PMID:10753731; https://doi.org/10.1086/315393
   PubMed Web of Science ®Google Scholar
• Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: a randomised controlled trial. Durban Immunotherapy Trial Group. Lancet 1999; 354:116-9; PMID:10408487; https://doi.org/10.1016/S0140-6736(98)10448-8
   PubMed Web of Science ®Google Scholar
• Dlugovitzky D, Bottasso O, Dominino JC, Valentini E, Hartopp R, Singh M, Stanford C, Stanford J. Clinical and serological studies of tuberculosis patients in Argentina receiving immunotherapy with Mycobacterium vaccae (SRL 172). Respir Med 1999; 93:557-62; PMID:10542989; https://doi.org/10.1016/S0954-6111(99)90155-5
   PubMed Web of Science ®Google Scholar
• Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 2. Chronic or relapsed disease. Respir Med 1997; 91:21-9; PMID:9068813; https://doi.org/10.1016/S0954-6111(97)90133-5
   PubMed Web of Science ®Google Scholar
• Corlan E, Marica C, Macavei C, Stanford JL, Stanford CA. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis in Romania. 1. Newly-diagnosed pulmonary disease. Respir Med 1997; 91:13-9; PMID:9068812; https://doi.org/10.1016/S0954-6111(97)90132-3
   PubMed Web of Science ®Google Scholar
• Skinner MA, Yuan S, Prestidge R, Chuk D, Watson JD, Tan PL. Immunizationwith heat-killed Mycobacterium vaccae stimulates CD8+ cytotoxic T cells spe-cific for macrophages infected with Mycobacterium tuberculosis. Infect Immun 1997; 65:4525-30; PMID:9353029
   PubMed Web of Science ®Google Scholar
• Zhang L, Ma W, Da J. Mycobacterium vaccae influences the kinetics of Th1/Th2cells and expression of iNOS in a marine model of experimental tuberculosis. Chin J Tuberc Respir Dis 2000; 23:43-6
   Google Scholar
• Kon OM, Goyal M, Filley E, Gleissberg G, Cunningham D, Rook GA, Shaw RJ. Mycobacterium vaccae: a study of safety and outcome measures. Respir Med 1998; 92:597-8; PMID:9692130; https://doi.org/10.1016/S0954-6111(98)90316-X
   PubMed Web of Science ®Google Scholar
• Stanford JL. Immunotherapy with Mycobacterium vaccae in the treatment of mycobacterial disease. J Infect 1999; 39:179-82; PMID:10714790; https://doi.org/10.1016/S0163-4453(99)90044-0
   PubMed Web of Science ®Google Scholar
• Stanford JL, Stanford CA, Grange JM, Lan NN, Etemadi A. Does immunotherapy with heat-killed Mycobacterium vaccae offer hope for the treatment of multi-drug-resistant pulmonary tuberculosis. Respir Med 2001; 95:444-7; PMID:11421500; https://doi.org/10.1053/rmed.2001.1065
   PubMed Web of Science ®Google Scholar
• Stanford JL, Stanford CA, O'Brien ME, Grange JM. Successful immunotherapy with Mycobacterium vaccae in the treatment of adenocarcinoma of the lung. Eur J Cancer 2008; 44:224-7; PMID:17928219; https://doi.org/10.1016/j.ejca.2007.08.021
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151:W65-94; PMID:19622512; https://doi.org/10.7326/0003-4819-151-4-200908180-00136
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org. Updated March, 2011
   Google Scholar